SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-23-002642
Filing Date
2023-02-13
Accepted
2023-02-13 17:13:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G/A biofortune_13ga_20221231.htm SC 13G/A 171634
2 EX-99.99 cntb-ex99_99.htm EX-99 14404
  Complete submission text file 0000950170-23-002642.txt   187576
Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Subject) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92416 | Film No.: 23619892
SIC: 2834 Pharmaceutical Preparations

Mailing Address COASTAL BLDG WICKHAMS CAY II PO BOX 2221 ROAD TOWN TORTOLA D8 NONE
Business Address COASTAL BLDG WICKHAMS CAY II PO BOX 2221 ROAD TOWN TORTOLA D8 NONE 86 512 5357 7866
BioFortune Inc (Filed by) CIK: 0001912836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G/A